Is tumor size the best predictor of outcome for papillary thyroid cancer?

Annals of Surgical Oncology

Volumn 13, Issue 11, 2006, Pages 1524-1528

  Cheema, Yusra ^a   Repplinger, Daniel ^a   Elson, Diane ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Papillary; Thyroid cancer; Thyroidectomy; Well differentiated

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHI SQUARE TEST; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAPILLOMA; PREDICTOR VARIABLE; SURVIVAL RATE; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 33751001783     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9176-8     Document Type: Article

References (13)

1. Pearce EN, Braverman LE. Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 2004; 89:3710-12.
2. Udelsman R, Chen H. The current management of thyroid cancer. Adv Surg 1999; 33:1-27.
3. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998; 83:2638-48.
4. Passler C, Scheuba C, Prager G, Kaczirek K, Kaserer K, Zettinig G, Niederle B. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004; 11:131-139.
5. Siironen P, Louhimo J, Nordling S, Ristimaki A, Maenpaa H, Haapiainen R, Haglund C. Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 2005; 26:57-64.
6. Das DK. Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants? Gerontology 2005; 51:149-54.
7. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992; 164:671-676.
8. Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005; 103:2269-73.
9. Chen H, Udelsman R. Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am 1998; 7:645-64.
10. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418.
11. Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 2005; 71:731-34.
12. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996; 18:127-32.
13. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992; 164:658-61.